ArticleSignal transduction and targeted therapy2026
Reprogramming the tumor microenvironment with antibody against membrane-proximal AXL to overcome immune checkpoint blockade resistance.
Zuming Yang et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.